M 617 (Levetiracetam 750 mg)
Pill imprint M 617 has been identified as Levetiracetam 750 mg.
Levetiracetam is used in the treatment of seizures; epilepsy; bipolar disorder; neuralgia; hyperekplexia (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 750 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- M 617
- Strength:
- 750 mg
- Color:
- White
- Size:
- 19.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Pyrrolidine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-5617
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
sodium lauryl sulfate
titanium dioxide
triacetin
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0822 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
More about levetiracetam
Consumer resources
- Levetiracetam
- Levetiracetam extended-release tablets
- Levetiracetam solution
- Levetiracetam tablets
- Levetiracetam (Advanced Reading)
- Levetiracetam Intravenous (Advanced Reading)
- Other brands: Keppra, Keppra XR, Spritam, Elepsia XR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
